Hinge Health, Inc. (HNGE) Research

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

Market snapshot

Symbol
HNGE
Price
$69.42
Day change
+3.55%
Market cap
$5.4B
P/E ratio
-10.70x
52-week range
30.08-70.72
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months
Analyst price target
$75.33

Recent news

  • Oura's IPO Could Reveal Whether Wellness Tech Is Finally Wall Street-Ready

    Oura Health is prepings its IPO, which will test whether public markets are ready for a new wave of health technology companies.

Peer companies

  • Akero Therapeutics, Inc. (AKRO)
  • Crinetics Pharmaceuticals, Inc. (CRNX)
  • Dyne Therapeutics, Inc. (DYN)
  • Immunovant, Inc. (IMVT)
  • Indivior Pharmaceuticals Inc (INDV)
  • Lantheus Holdings, Inc. (LNTH)
  • Oscar Health, Inc. (OSCR)
  • Praxis Precision Medicines, Inc. (PRAX)

Recent insider activity

  • Insight Holdings Group, LLC — C-Conversion (32751 shares) on 2026-06-16
  • Insight Holdings Group, LLC — C-Conversion (26856 shares) on 2026-06-16
  • Insight Holdings Group, LLC — C-Conversion (5195 shares) on 2026-06-16
  • Insight Holdings Group, LLC — C-Conversion (779 shares) on 2026-06-16
  • Insight Holdings Group, LLC — C-Conversion (32751 shares) on 2026-06-16

Open Hinge Health, Inc. (HNGE) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.